Cagrilintide Peptide: Long-Acting Amylin Analog Guide

Cagrilintide is a long-acting amylin analogue, and the cagrilintide peptide has been studied in clinical trials for effects on appetite and body weight. This guide covers its structure, mechanism, trial results and regulatory status. VivePeptides sells its cagrilintide research vial for laboratory research use only.

By Vive Peptides Team

What Is Cagrilintide?

What is cagrilintide? It is a synthetic peptide (a short chain of amino acids) designed to mimic amylin, a hormone the pancreas releases alongside insulin. Novo Nordisk developed it, and the cagrilintide peptide has been tested in preclinical models and in published clinical trials, mostly in adults with overweight or obesity. This overview treats it as a research compound.

The amylin hormone normally rises after meals. It slows gastric (stomach) emptying, signals fullness to the brain, and reduces the release of glucagon, a pancreatic hormone that raises blood sugar. Researchers study cagrilintide to understand how that pathway shapes appetite and weight management in model systems. VivePeptides lists the material strictly for research use only, not for human or veterinary use.

What Is the Cagrilintide Peptide's Structure and Half-Life?

Native amylin has 37 amino acids and clears from the bloodstream within minutes. Cagrilintide keeps an amylin-like backbone but adds sequence changes and an attached fatty acid chain. That chain gives the cagrilintide long-acting profile, because it lets the molecule bind albumin, a carrier protein in blood, which slows clearance.

How long does cagrilintide last in the body?

Human pharmacokinetics studies (how a compound is absorbed and cleared) report a half-life of roughly one week. That figure explains why published trials used once-weekly administration. Half-life is the time for a concentration to fall by half, so full clearance takes several half-lives. These numbers describe a pharmaceutical formulation in clinical studies. They do not predict stability in any laboratory setting, where buffer, temperature and handling matter.

Purity matters for any structure-based work. Product pages across the research-grade peptide catalog carry a technical profile that lists HPLC testing, a purity of 99% or higher, lyophilized powder and storage at -20°C. HPLC (high-performance liquid chromatography) separates a sample into its components so purity can be measured. VivePeptides product pages carry a '99%+ Purity' badge and a 'USA Made' origin badge, and state that products are sold strictly for laboratory and research use only. The cagrilintide listing sits in the research catalog, and the site describes third-party testing in USA labs.

What Is the Cagrilintide Mechanism of Action?

The cagrilintide mechanism of action starts at receptors. Cagrilintide is a receptor agonist, meaning it binds a receptor and switches it on. Its main targets are amylin receptors, which form when the calcitonin receptor pairs with a helper protein called RAMP (receptor activity-modifying protein). Because it also activates the calcitonin receptor alone, researchers describe it as a dual amylin and calcitonin receptor agonist.

What receptor does cagrilintide target?

Amylin receptors and the calcitonin receptor, all of them G protein-coupled receptors on the cell surface. These receptors are dense in the brainstem, including the area postrema, a region that samples blood-borne signals. In animal models, activating them reduced food intake, slowed gastric emptying and lowered glucagon release after meals. Researchers read that pattern as appetite signaling plus slower nutrient delivery. How much each effect contributes in humans is still an open research question.

How Does the Cagrilintide Amylin Analog Differ From Native Amylin?

An amylin analog is a lab-made version of amylin with deliberate changes. Native amylin, also called islet amyloid polypeptide, has two practical limits for experiments: it clears within minutes, and it can aggregate into amyloid fibrils (insoluble protein clumps). The cagrilintide amylin analogue was engineered to address both. It is also its own molecule, with amylin and calcitonin receptors as its targets.

• Duration: native amylin clears within minutes, while cagrilintide has a reported half-life near one week in humans.
• Aggregation: native amylin forms amyloid fibrils, and cagrilintide's sequence changes limit that tendency.
• Receptor profile: both engage amylin receptors, and cagrilintide also acts as an agonist at the calcitonin receptor.
• Shared target: experiments with the analogue still probe the native hormone pathway, which is the reason to use an analogue as a research tool.

What Does Cagrilintide Research Show in Clinical Trials?

Human cagrilintide research comes mainly from trials sponsored by Novo Nordisk. The best-known early study is a multicentre (run at several sites), randomised, double-blind, placebo-controlled phase 2 trial in adults with overweight or obesity, published by Lau and colleagues in The Lancet in 2021. Over 26 weeks, weight loss was dose-dependent. The highest weekly dose group (4.5 mg) reached a mean reduction of 10.8 percent, against 3.0 percent with placebo, according to the paper.

Reported side effects were mostly gastrointestinal, with nausea, constipation and diarrhea the most common, and most events were mild to moderate. Tolerability was a key endpoint alongside efficacy. That efficacy figure describes a prescription-development product in a defined trial population. It says nothing about the research material VivePeptides sells.

Readers can verify any trial by its PMID, the PubMed identifier printed on every PubMed record. Matching a PMID to the ClinicalTrials.gov registry entry confirms the sponsor, design and endpoints. A claim with no traceable PMID deserves caution, because cagrilintide research is easy to misquote.

CagriSema FDA Approval: Is Cagrilintide Approved as a Standalone Drug?

No. Public records at the time of writing show no FDA-approved drug that lists cagrilintide as its only active ingredient. The FDA (US Food and Drug Administration) approves specific prescription products after reviewing trial data, so a compound name alone carries no approval. If a product containing cagrilintide is ever approved, that approval covers the prescription product, not research material.

Novo Nordisk has also run later-phase clinical trials that pair cagrilintide with a second peptide, a combination known as CagriSema. A combination is a different product from cagrilintide alone, with its own trial data and safety record, so results for one cannot be assigned to the other. Regulatory status for any combination changes as reviews proceed, so check Drugs@FDA and the sponsor's announcements for the current position.

Questions People Ask About Cagrilintide Research

How long does cagrilintide stay in the body?

Published human pharmacokinetics report a half-life of roughly one week for the clinical formulation, so measurable levels can persist for weeks. Native amylin, by comparison, clears within minutes. These figures come from clinical studies of a pharmaceutical product, and VivePeptides makes no claim about duration for its research material.

Can cagrilintide be studied on its own?

Yes. The 2021 multicentre phase 2 trial tested cagrilintide as a single agent against placebo, and preclinical work often uses it alone to isolate amylin receptor effects. Novo Nordisk clinical trials also pair it with a second peptide. Every result describes a defined study protocol, not guidance for any individual.

Can any health benefit be claimed for cagrilintide?

No. VivePeptides sells cagrilintide for research use only and makes no health claim for it. Trial reports describe measured outcomes in defined populations, including side effects such as nausea, and the FDA has not approved cagrilintide as a standalone drug. Questions about human health belong with published trial data and a licensed clinician.

Where can researchers buy cagrilintide peptide online in the USA?

VivePeptides is a US-based supplier that lists cagrilintide as a research-use-only product. Payment options are shown at checkout, and buyers should confirm accepted card types there before ordering. A free bottle of BAC Water is included with any peptide order and is not sold separately. Check the live product page for current pricing. Wholesale buyers should use the wholesale contact form.

Check Cagrilintide Specifications Before Planning a Study

Researchers comparing materials can read the full specification block, including HPLC purity, on the cagrilintide 10 mg product page.